Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01060345
What this trial is testing

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

Who this might be right for
Ductal Carcinoma in Situ
University of Chicago 20
Not applicableActive Not RecruitingNCT02306538
What this trial is testing

Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI

Who this might be right for
Breast Neoplasms
University Health Network, Toronto 180
Testing effectiveness (Phase 2)UnknownNCT03961698
What this trial is testing

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Who this might be right for
Breast CancerRenal Cell Carcinoma
Infinity Pharmaceuticals, Inc. 91
Testing effectiveness (Phase 2)Ended earlyNCT00461344
What this trial is testing

Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer

Who this might be right for
Ductal Carcinoma
Sanofi 20
Early research (Phase 1)UnknownNCT04764084
What this trial is testing

Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors

Who this might be right for
HER2-negative Breast CancerGastric AdenocarcinomaCholangiocarcinoma+1 more
Peking University Cancer Hospital & Institute 52
Not applicableNot Yet RecruitingNCT06217458
What this trial is testing

The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS

Who this might be right for
DCISBreast Carcinoma in SituCalcification
Clinical Hospital Center Rijeka 100
Testing effectiveness (Phase 2)UnknownNCT01292408
What this trial is testing

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients

Who this might be right for
Breast Cancer
Radboud University Medical Center 20
Early research (Phase 1)UnknownNCT03749850
What this trial is testing

Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer

Who this might be right for
Metastatic Breast CancerBreast CancerBreast Neoplasms+5 more
UMC Utrecht 12
Not applicableActive Not RecruitingNCT07259304
What this trial is testing

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+97 more
University of Southern California 118
Testing effectiveness (Phase 2)WithdrawnNCT01008514
What this trial is testing

Partial-Breast Radiation Therapy in Treating Women With Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center
Not applicableStudy completedNCT01815476
What this trial is testing

The Prone Breast Radiation Therapy Trial

Who this might be right for
Ductal Carcinoma In SituInvasive Breast Cancer
Toronto Sunnybrook Regional Cancer Centre 378
Large-scale testing (Phase 3)Study completedNCT01583426
What this trial is testing

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)

Who this might be right for
Tubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more
GBG Forschungs GmbH 1,229
Early research (Phase 1)Study completedNCT00526617
What this trial is testing

A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

Who this might be right for
Non-hematologic MalignanciesMetastatic MelanomaBreast Cancer+4 more
AbbVie 41
Testing effectiveness (Phase 2)Looking for participantsNCT07432633
What this trial is testing

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Who this might be right for
Colorectal CancerEpithelial Ovarian CancerGastric Cancer+2 more
Blue Earth Diagnostics 71
Testing effectiveness (Phase 2)Looking for participantsNCT03936478
What this trial is testing

Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer

Who this might be right for
Breast CancerDCISLCIS
University of Wisconsin, Madison 30
Early research (Phase 1)Study completedNCT01730118
What this trial is testing

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

Who this might be right for
Breast NeoplasmsBreast CancerAdenocarcinomas+1 more
National Cancer Institute (NCI) 33
Large-scale testing (Phase 3)Temporarily pausedNCT06671912
What this trial is testing

Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8+4 more
Alliance for Clinical Trials in Oncology 1,556
Not applicableStudy completedNCT03375892
What this trial is testing

The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure

Who this might be right for
Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
Medical College of Wisconsin 11
Not applicableActive Not RecruitingNCT03075072
What this trial is testing

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

Who this might be right for
Brain Metastases
Dana-Farber Cancer Institute 196
Early research (Phase 1)Study completedNCT01131234
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more
National Cancer Institute (NCI) 20
Next Page